126
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Platelet Count within the Normal Range at Hospital Admission is Associated with Mortality in Patients with Community-Acquired Pneumonia

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 711-716 | Published online: 07 Jul 2020

References

  • Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123(18):2759–2767. doi:10.1182/blood-2013-11-46243224585776
  • Xu XR, Zhang D, Oswald BE, et al. Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016;53(6):409–430. doi:10.1080/10408363.2016.120000827282765
  • Parikh F. Infections and Thrombocytopenia. J Assoc Physicians India. 2016;64(2):11–12.
  • Anderson R, Feldman C. Review manuscript: mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia. J Infect. 2017;75(6):473–485. doi:10.1016/j.jinf.2017.09.01328943342
  • Aliberti S, Amir A, Peyrani P, et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest. 2008;134(5):955–962. doi:10.1378/chest.08-033418583514
  • Mirsaeidi M, Peyrani P, Aliberti S, et al. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest. 2010;137(2):416–420. doi:10.1378/chest.09-099819837825
  • Prina E, Ferrer M, Ranzani OT, et al. Thrombocytosis is a marker of poor outcome in community-acquired pneumonia. Chest. 2013;143(3):767–775. doi:10.1378/chest.12-123523187959
  • Brogly N, Devos P, Boussekey N, et al. Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect. 2007;55(2):136–140. doi:10.1016/j.jinf.2007.01.01117350105
  • Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
  • Grann AF, Erichsen R, Nielsen AG, Frøslev T, Thomsen RW. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol. 2011;3:133–138. doi:10.2147/CLEP.S1790121487452
  • Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–33. doi:10.1177/140349481140148221775347
  • Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
  • Thomsen RW, Riis A, Nørgaard M, et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med. 2006;259(4):410–417. doi:10.1111/j.1365-2796.2006.01629.x16594909
  • Ingeman A, Andersen G, Hundborg HH, Johnsen SP. Medical complications in patients with stroke: data validity in a stroke registry and a hospital discharge registry. Clin Epidemiol. 2010;2:5–13. doi:10.2147/CLEP.S890820865097
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
  • Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish national registry of patients. BMC Med Res Methodol. 2011;11:83. doi:10.1186/1471-2288-11-8321619668
  • Ludvigsson JF, Håberg SE, Knudsen GP, et al. Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol. 2015;7:491–508. doi:10.2147/CLEP.S9058926648756
  • Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol. 2005;238(1):1–9. doi:10.1016/j.cellimm.2005.12.00516442516
  • Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J. 2002;20(4):990–995. doi:10.1183/09031936.02.0029510212412694
  • Rae N, Finch S, Chalmers JD. Cardiovascular disease as a complication of community-acquired pneumonia. Curr Opin Pulm Med. 2016;22(3):212–218. doi:10.1097/MCP.000000000000026126886878
  • Greinacher A, Selleng SS. I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood. 2016;128(26):3032–3042. doi:10.1182/blood-2016-09-69365528034871
  • Bedet A, Razazi K, Boissier F, et al. Mechanisms of thrombocytopenia during septic shock: a multiplex cluster analysis of endogenous sepsis mediators. Shock. 2018;49(6):641–648. doi:10.1097/SHK.000000000000101529028771
  • Moulis G, Christiansen CF, Darvalics B, Nørgaard M. Prevalence of thrombocytopenia and thrombocytosis upon acute hospital admission to internal medicine units. A cross-sectional study in Denmark. Eur J Intern Med. 2018;57:e34–e37. doi:10.1016/j.ejim.2018.08.01430177488
  • Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi:10.1136/thorax.58.5.37712728155
  • Gorelik O, Tzur I, Barchel D, et al. A rise in mean platelet volume during hospitalization for community-acquired pneumonia predicts poor prognosis: a retrospective observational cohort study. BMC Pulm Med. 2017;17(1):137. doi:10.1186/s12890-017-0483-629084523
  • Gorelik O, Izhakian S, Barchel D, et al. Prognostic significance of platelet count changes during hospitalization for community-acquired pneumonia. Platelets. 2016;1–7.26695713